Walking Pneumonia, the Beginning of Influenza Season, and Does Antiv…

MicrobeTV

D. Griffin, V. Racaniello

Nirsevimab for RSV: A Breakthrough Product for Babies

MicrobeTV

P. Offit, V. Racaniello

IDWeek 2024 Insights: To Mask or Not to Mask - Approaches to Source …

IDWeek 2024 Insights

E. Landon

Hydrocortisone Reduces Mortality by 48% in Severe Community-Acquired…

MedCram

R. Seheult

What to Know About the FDA Authorization and Approval of Updated COV…

Amesh Adalja

Preparing for Winter: CDC Recommendations for Influenza, COVID-19, a…

Diego Hijano

What's New with COVID in 2024?

Michigan Medicine

L. Washer

Newly Licensed Respiratory Syncytial Virus Vaccines for Adults: What…

MicrobeTV

P. Offit, V. Racaniello

Understanding Changes in Acute Care and Mortality Patterns Among Chi…

Christina Belza

Preventing Complications with Vaccines in Persons with Diabetes (PWD)

Allison Presnell

Durability of Protection Following Administration of Recombinant Ant…

MicrobeTV

D. Griffin, V. Racaniello

Mpox Circulation and New Vaccine Approval, Largest Outbreak of Whoop…

MicrobeTV

D. Griffin, V. Racaniello

IDWeek 2024 Insights: COVID-19 in Children - Navigating the Current …

IDWeek 2024 Insights

I. Anosike

Vaccination vs. Antiviral Therapy Against Mpox, Authorization and Ap…

MicrobeTV

D. Griffin, V. Racaniello

September 2024 Public Health Infectious Disease Updates

California Medical Association

E. Pan

CHEST 2024 Insights: Vaccination Challenges and Strategies for Viral…

CHEST Annual Meeting Insights

A. Kapoor

Update on Adult Immunizations (July 2024): Part 1

Barbara Yawn

The Role of the Nervous System In Chronic Illness

The Institute for Neuro-Immune Medicine

H. Pomroy, D. Kantor

Update on Adult Immunizations (July 2024): Part 2

Barbara Yawn

Project 2025 vs. the Public's Health Part III: The NIH

MicrobeTV

P. Offit, V. Racaniello